Pradeep Chaluvally-Raghavan, PhD

Publications

• miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer.

  (Parashar D, Geethadevi A, Aure MR, Mishra J, George J, Chen C, Mishra MK, Tahiri A, Zhao W, Nair B, Lu Y, Mangala LS, Rodriguez-Aguayo C, Lopez-Berestein G, Camara AKS, Liang M, Rader JS, Ramchandran R, You M, Sood AK, Kristensen VN, Mills GB, Pradeep S, Chaluvally-Raghavan P.) Cell Rep. 2019 Dec 24;29(13):4389-4406.e10 PMID: 31875548 SCOPUS ID: 2-s2.0-85076674271 12/26/2019

• B Cells as an Immune-Regulatory Signature in Ovarian Cancer.

  (Gupta P, Chen C, Chaluvally-Raghavan P, Pradeep S.) Cancers (Basel). 2019 Jun 26;11(7) PMID: 31248034 PMCID: PMC6678944 SCOPUS ID: 2-s2.0-85068665327 06/30/2019

• Interaction of tumor cells and astrocytes promotes breast cancer brain metastases through TGF-β2/ANGPTL4 axes.

  (Gong X, Hou Z, Endsley MP, Gronseth EI, Rarick KR, Jorns JM, Yang Q, Du Z, Yan K, Bordas ML, Gershan J, Deepak P, Geethadevi A, Chaluvally-Raghavan P, Fan Y, Harder DR, Ramchandran R, Wang L.) NPJ Precis Oncol. 2019;3:24 PMID: 31602400 PMCID: PMC6776663 10/12/2019

• ERBB signaling in CTCs of ovarian cancer and glioblastoma.

  (Geethadevi A, Parashar D, Bishop E, Pradeep S, Chaluvally-Raghavan P.) Genes Cancer. 2017 Nov;8(11-12):746-751 PMID: 29321816 PMCID: PMC5755720 SCOPUS ID: 2-s2.0-85042923599 01/13/2018

• miRNA-Mediated RNA Activation in Mammalian Cells.

  (Ramchandran R, Chaluvally-Raghavan P.) Adv Exp Med Biol. 2017;983:81-89 PMID: 28639193 SCOPUS ID: 2-s2.0-85021314316 06/24/2017

• Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer.

  (Chaluvally-Raghavan P, Jeong KJ, Pradeep S, Silva AM, Yu S, Liu W, Moss T, Rodriguez-Aguayo C, Zhang D, Ram P, Liu J, Lu Y, Lopez-Berestein G, Calin GA, Sood AK, Mills GB.) Cell Rep. 2016 05 17;15(7):1493-1504 PMID: 27160903 PMCID: PMC4914391 SCOPUS ID: 2-s2.0-84964941322 05/11/2016

• Targeting ncRNAs in the 3q26.2 amplicon.

  (Chaluvally-Raghavan P, Mills GB.) Oncoscience. 2015;2(8):671-2 PMID: 26425652 PMCID: PMC4580054 10/02/2015

• Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers.

  (Chaluvally-Raghavan P, Zhang F, Pradeep S, Hamilton MP, Zhao X, Rupaimoole R, Moss T, Lu Y, Yu S, Pecot CV, Aure MR, Peuget S, Rodriguez-Aguayo C, Han HD, Zhang D, Venkatanarayan A, Krohn M, Kristensen VN, Gagea M, Ram P, Liu W, Lopez-Berestein G, Lorenzi PL, Børresen-Dale AL, Chin K, Gray J, Dusetti NJ, McGuire SE, Flores ER, Sood AK, Mills GB.) Cancer Cell. 2014 Dec 08;26(6):863-879 PMID: 25490449 PMCID: PMC4261159 SCOPUS ID: 2-s2.0-84919477596 12/10/2014

• Hematogenous metastasis of ovarian cancer: rethinking mode of spread.

  (Pradeep S, Kim SW, Wu SY, Nishimura M, Chaluvally-Raghavan P, Miyake T, Pecot CV, Kim SJ, Choi HJ, Bischoff FZ, Mayer JA, Huang L, Nick AM, Hall CS, Rodriguez-Aguayo C, Zand B, Dalton HJ, Arumugam T, Lee HJ, Han HD, Cho MS, Rupaimoole R, Mangala LS, Sehgal V, Oh SC, Liu J, Lee JS, Coleman RL, Ram P, Lopez-Berestein G, Fidler IJ, Sood AK.) Cancer Cell. 2014 Jul 14;26(1):77-91 PMID: 25026212 PMCID: PMC4100212 SCOPUS ID: 2-s2.0-84904265681 07/16/2014